Location History:
- Muender, DE (2009)
- Bad Muender, DE (1997 - 2010)
- Bad Münder, DE (2010)
- Münder, DE (2011)
Company Filing History:
Years Active: 1997-2011
Title: The Innovative Contributions of Jochen Antel
Introduction
Jochen Antel, an accomplished inventor based in Bad Muender, Germany, holds an impressive portfolio of 18 patents. His pioneering work primarily focuses on pharmaceutical innovations aimed at treating obesity and related health conditions. Antel's innovative thinking has led to significant advancements in the field of medical therapies.
Latest Patents
Among Jochen Antel’s latest patents is a groundbreaking invention pertaining to pharmaceutical compositions that combine CB1 cannabinoid receptor antagonists and potassium channel openers for the effective treatment of obesity and associated conditions. This novel approach describes a combination therapy that addresses diabetes mellitus type I and II, alongside metabolic syndrome and other secondary diseases. By utilizing a blend of potassium channel openers and cannabinoid receptor antagonists, this innovative treatment provides a dual-action mechanism beneficial to patients.
Another significant patent involves N-sulfamoyl-piperidineamides, which are designed to treat or inhibit obesity and its related complications. This invention encompasses novel compounds and their physiologically acceptable salts, highlighting their efficacy in pharmaceutical compositions aimed at combating obesity and its comorbidities.
Career Highlights
Jochen Antel's career includes significant contributions while working with reputable companies like Solvay Pharmaceuticals GmbH and Abbott Products GmbH. His experiences at these organizations have enriched his expertise in pharmaceutical development and innovation.
Collaborations
Throughout his career, Antel has collaborated with notable professionals, including Holger Sann and Harald Waldeck, enhancing the collaborative spirit in his research endeavors. These partnerships have likely played a crucial role in the successful development of his patented innovations.
Conclusion
In summary, Jochen Antel's contributions to pharmaceutical innovations, particularly in treating obesity and diabetes, have made him a notable figure in the field of medical research. His inventions, characterized by their dual-action therapies, hold promise for improving health outcomes for many individuals grappling with these conditions. As he continues to pave the way for future advancements, Antel's work will undoubtedly remain influential in the realm of pharmaceutical sciences.